ALPS Advisors’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-30,358
| Closed | -$146K | – | 965 |
|
|
2023
Q3 | $146K | Buy |
30,358
+317
| +1% | +$1.52K | ﹤0.01% | 965 |
|
|
2023
Q2 | $226K | Buy |
30,041
+3,191
| +12% | +$24K | ﹤0.01% | 971 |
|
|
2023
Q1 | $121K | Sell |
26,850
-853
| -3% | -$3.86K | ﹤0.01% | 995 |
|
|
2022
Q4 | $312K | Buy |
27,703
+5,449
| +24% | +$61.4K | ﹤0.01% | 847 |
|
|
2022
Q3 | $213K | Sell |
22,254
-1,876
| -8% | -$18K | ﹤0.01% | 998 |
|
|
2022
Q2 | $195K | Sell |
24,130
-17,634
| -42% | -$143K | ﹤0.01% | 998 |
|
|
2022
Q1 | $706K | Sell |
41,764
-5,108
| -11% | -$86.3K | 0.01% | 350 |
|
|
2021
Q4 | $1.01M | Sell |
46,872
-2,576
| -5% | -$55.3K | 0.01% | 358 |
|
|
2021
Q3 | $3.65M | Sell |
49,448
-3,234
| -6% | -$239K | 0.04% | 196 |
|
|
2021
Q2 | $2.88M | Buy |
+52,682
| New | +$2.88M | 0.03% | 223 |
|